Atypical pneumonia revisited

Seminars in Respiratory and Critical Care Medicine

Volumn 17, Issue 3, 1996, Pages 221-229

  Marrie, Thomas J ^a,b  

^a DALHOUSIE UNIVERSITY   (Canada)

^b NONE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHLAMYDOPHILA PNEUMONIAE; CHLAMYDOPHILA PSITTACI; CLINICAL FEATURE; DISEASE COURSE; HANTAVIRUS; HOSPITALIZATION; LEGIONNAIRE DISEASE; MYCOPLASMA PNEUMONIA; ORNITHOSIS; PRIORITY JOURNAL; Q FEVER; REVIEW; SYMPTOMATOLOGY; VIRUS PNEUMONIA;

EID: 0029897503     PISSN: 10693424     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1009892     Document Type: Review

References (128)

1. Reimann HA. An acute infection of the respiratory tract with atypical pneumonia, A disease entity probably caused by a filterable virus. JAMA 1938;111:2377-84
2. Harris RL, Williams TW. Contribution to the question of pneumotyphus. A discussion of the original article by J. Ritter in 1880. Rev Infect Dis 1985;7:119-22
3. Derrick EH. "Q" fever, new fever entity: clinical features, diagnosis and laboratory investigation. Med J Austr 1937;2:281-99
4. Eaton MD, Meikeljohn G, van Herick W. Studies on the etiology of primary atypical pneumonia. II. Properties of the virus isolated and propagated in chicken embryos. J Exp Med 1945;82:317-22
5. Fraser DW, Tsai TR, Orenstein W, et al. Field investigation Team. Legionnaires' disease. Description of an epidemic of pneumonia. N Engl J Med 1977;297:1189-97
6. Grayston JT, Kuo CC, Wang SP, Altman J. A new Chlamydia psittaci strain called TWAR from acute respiratory tract infections. X Engl J Med 1986;315:161-3
7. Duchin JS, Koster FT, Peters CJ, et al and the Hantavirus Study Group. Hantavirus pulmonary syndrome: a clinical description of 17 patients with newly recognized disease. N Engl J Med 1994;330:949-55
8. Luby JP. Southwestern Internal Medicine Conference: Pneumonias in adults due to Mycoplasma, Chlamydia, and viruses. Am J Med Sci 1987;30:45-64
9. Cunha BA, Quintiliani R. The atypical pneumonias, a diagnostic and therapeutic approach. Postgrad Med 1979;66:95-102
10. Fang G, Fine M, Orloff J, et al. New and emerging etiologies for community-acquired pneumonia with implications for therapy. Medicine 1990;69:307-16
11. British Thoracic Society and Public Health Laboratory Service. Community-acquired pneumonia in adults in British hospitals in 1982-1983: a survey of aetiology, mortality, prognostic factors and outcome. Quart J Med 1987;239:195-220
12. Ortqvist A, Hedlund J, Grillner L, Jalonen E. Aetiology, outcome and prognostic factors in community-acquired pneumonia requiring hospitalization. Eur Respir J 1990: 3:1105-13
13. Blanquer J, Blanquer R, Borras R, Nauffald D. Etiology of community-acquired pneumonia in Valencia, Spain: a multicentre prospective study. Thorax 1991:46:508-16
14. Marrie TJ, Durant H, Yates L. Community-acquired pneumonia requiring hospitalizauon: 5 year prospective study. Rev Infect Dis 1989;11:586-99
15. Erard PH, Moser F, Wenger A, et al, and a group of practitioners at Neuchatel. Prospective study on communityacquired pneumonia diagnosed and followed by private practitioners. Abstracts of the 1991 Intcrscience Conference on Antimicrobial Agents and Chemotherapy. Am Soc Microbiol 1991;108(Abstract 56)
16. Woodhead MA, MacFarlane JT, McCracken JS, et al. Prospective study of the aetiology and outcome of pneumonia in the community. Lancet 1987;11:671-4
17. Langille DB, Yates L, Marrie TJ. Serological investigation of pneumonia as it presents to the physician's office. Can J Infect Dis 1993;4:328-32
18. McCaul TF, Williams JC. Development cycle of Coxiella burnetii: structure and morphogenesis of vegetative and sporagenic differentiations. J Bacteriol 1981;147:1063-76
19. Stoker MGP, Fiset P. Phase variation of the nine mile and other strains of Rickettsia burneii. Can J Microbiol 1956;2:310-21
20. Babudieri B. Q fever: a zoonosis. Adv Vet Sci 1959:5:81-182
21. Luoto L, Huebner RJ. Q fever studies in Southern California. IX. Isolation of Q fever organisms from parturient placentas of naturally infected cows. Public Health Rep 1950;65:541-4
22. Aitken ID. Clinical aspects and prevention of Q fever in animals. Eur J Epidemiol 1989;5:420-4
23. Parker RR, Bell EJ, Lackman DB. Experimental studies of Q fever in cattle. I. Observations in four heifers and two milk cows. Am J Hyg 1948;48:191-206
24. Parker RR, Bell EJ, Stoenner HG. Q fever - A brief survey of the problem. J Am Vet Med Assoc 1949:114:55-60
25. Welsh HH, Lennette EH, Abinanti FR, Winn JF. Q fever in California: IV. Occurrence of Coxiella burnetn in the birth fluids of naturally infected sheep. Am J Hyg 1953;58:385-8
26. Marrie TJ, Durant H, Williams JC, et al. Exposure to parturient cats is a risk factor for acquisition of Q fever in Maritime Canada. J Infect Dis 1988;158:101-8
27. Smith DL, Ayres JG, Blair I, et al. A large Q fever outbreak in the West Midlands: clinical aspects. Respir Med 1993;87:509-16
28. Luoto L, Casey ML, Pickens EG. Q fever studies in Montana. Detection of asymptomatic infection among residents of infected dairy premises. Am J Epidemiol 1965;85:356-69
29. Clark WH, Lennette EH, Railsback OC, Romer MS. Q fever in California. VII. Clinical features in one hundred and eighty cases. .Arch Intern Med 1951;88:155-67
30. Spelman DW. Q fever: A study of 111 consecutive cases. MedJ Aust 1981;1:547-53
31. Dupuis G, Peter O, Pedroni D, Petite J. Aspects cliniques observes lors d'une epidemie de 415 cas de fievre Q. Schweiz Med Wochenschr 1985;115:814-8
32. Somma-Moreira RE, Caffarena RM, Somma S, et al. Analysis of Q fever in Uruguay. Rev Infect Dis 1987; 9:386-7
33. Sempere AP, Elizaga J, Duarte J, et al. Q fever mimicking herpetic encephalitis. Neurol 1993;43:2713-4
34. Brada M, Bellingham AJ. Bone marrow necrosis and Q fever. Br Med J 1980;210:1108-9
35. Estrov Z, Bruck R, Shtalrid M, et al. Histiocytic hemophagocytosis in Q fever. Arch Pathol Lab Med 1984;108:7
36. Cardellach F, Font J, Agusti AGN, et al. Q fever and hemolytic anemia. J Infect Dis 1983;148:769
37. Ramos HS, Hodges RE, Meroney WH. Q fever: report of a case simulating lyrnphoma. Ann Intern Med 1957;47: 1030-5
38. Hitchins R, Cobcroft RG, Hocker G. Transient severe hypoplastic anemia in Q fever. Pathology 1986;18:254-5
39. Baumbach A, Brehm B, Sauer W, et al. Spontaneous splenic rupture complicating acute Q fever. Am J Gastroenterol 1992;87:1651-3
40. Schuil J, Richardus JH, Baarsma GS, et al. Q fever as a possible cause of bilateral optic neuritis. Br J Ophthalmol 1985;69:580-3
41. Conget I, Mallolas J, Mensa J, et al. Erythema nodosum and Q fever. Arch Dermatol 1987;123:867
42. Field PR, Hunt JG, Murphy AM. Detection and persistence of specific IgM antibody to Coxiella burnetii by enzymelinked immunoabsorbent assay: a comparison with immunofluorescence and complement fixation tests. J Infect Dis 1983;148:477-87
43. Peter O, Dupuis G, Burgdorfer W, et al. Evaluation of the complement fixation and indirect immunofluorescence test in the early diagnosis of primary Q fever. Eur J Clin Microbiol 1985;4:394-6
44. Sobradillo V, Zalacain R, Capelastequi A, et al. Antibiotic treatment in pneumonia due to Q fever. Thorax 1992;47:276-8
45. Perez-del-Molino A, Aguado JM, Riancho JA, et al. Erythromycin and the treatment of Coxiella bumetn pneumonia. J Antimicrob Chemother 1991;28:455-9
46. Yeaman MR, Mitscher LA, Baca OG. In vitro susceptibility of Coxiella burnetii for antibiotics, including several quinolones. Antimicrob Agents Chemother 1987;31: 1079-84
47. Yeaman MR, Baca OG. Mechanisms that may account for differential antibiotic susceptibility among Coxiella bernetiisolates. Antimicrob Agents Chemother 1991;35:948-54
48. Maurin M, Benoliel AM, Bongrand P, Raoult D. Phagolysosomal alkalinization and the bactericidal effect of antibiotics. The Coxiella burnetii paradigm. J Infect Dis 1992;166:1097-1102
49. Raoult D, Torres H, Drancourt M. Shell-vial assays: evaluation of a new technique for determining antibiotic susceptibility, tested in 13 isolates of Coxiella burnetii. Antimicrob Agents Chemother 1991;35:2070-7
50. Marrie TJ. Mycoplasma pneumonias pneumonia requiring hospitalization, with emphasis on infection in the elderly. Arch Intern Med 1993;153:488-94
51. Levine DP, Lerner AM. The clinical spectrum of Mycoplasma pneumoniae infections. Med Clin North Am 1978;62:961-78
52. Mansel JK, Rosenow EC, Smith TF, Martin JW. Mycoplasma pneumoniae pneumonia. Chest 1989;95:639-46
53. Shulman ST, Bartlett J. Clyde WA, Ayoub EM. The unusual severity of mycoplasmal pneumonia in children with sickle-cell disease. N Engl J Med 1972:287:164-7
54. Ali NJ, Sillis M, Andrews BE, et al. The clinical spectrum and diagnosis of Mycoplasma pneumoniae infection. Quart J Med 1986;58:241-51
55. Fischman RA, Marschall KE, Kislak JW, Greenbaum DM. Adult respiratory distress syndrome caused by Mycoplasma pneumoniae. Chest 1978;74:471-3
56. Koletsky RJ. Weinstein AJ. Fulminant Mycoplasma pneumoniae infecuon. Am Rev Respir Dis 1980;122:491-6
57. Tablan OC, Reyes MP. Chronic interstitial pulmonary fibrosis following Mycoplasma pneumoniae pneumonia. Am J Med 1985:79:268-70
58. Kaufman JM, Cuvelier CA, Van der Straeten M. Mycoplasma pneumonia with fulminant evolution into diffuse interstitial fibrosis. Thorax 1980;35:140-4
59. Cimolai N, Mah D, Roland E. Anticentriolar autoantibodies in children with central nervous system manifestations of Mycoplasma pneumoniae infection. J Neurol Neurosurg Psych 1994;57:638-9
60. Ishida K, Kaku M, Irifune K, et al. In vivo and in vitro activities of macrolides against Mycoplasma pneumoniae. Antimicrob Agents Chemother 1994;38:790-8
61. Kenny GE, Cartwright FD. Susceptibilities of Mycoplasma hominis. Mycoplasma- pneumoniae, and Ureaplasma ureolyticum to new glycyclines in comparison with those to older tetracyclines. Antimicrob Agents Chemother 1994;38:2628-32
62. Tjhie JH, van Kuppeveld FJM, Roosendaal R, et al. Direct PCR enables detection of Mycoplasma pneumoniae in patients with respiratory tract infections. J Clin Microbiol 1994;32:11-6
63. McDade JE, Shepard CC, Fraser DW, et al. Legionnaires' disease. Isolation of a bacterium and demonstration of its role in other respiratory disease. N Engl J Med 1977;297:1197-1203
64. Glick TH, Gregg MB, Berman B, et al. 1. Pontiac fever. An epidemic of unknown aetiology in a health department. 1. Clinical and epidemiologic aspects. Am J Epidemiol 1978;107:149-160
65. Kirby BD, Snyder KM, Meyer RD, et al. Legionnaires' disease: clinical features of 24 cases. Ann Int Med 1978; 89:297-309
66. Gregory DW, Schaffner W, Alford RH, et al. Sporadic cases of Legionnaires' disease. The expanding clinical spectrum. Ann Intern Med 1979;90:518-21
67. Brenner DJ. Classification of the Legionellae. Semin Respir Infect 1987:2:190-205
68. Marston BJ, Lipman HB. Breiman RF. Surveillance for Legionnaires' disease. Risk factors for morbidity and mortality. Arch Intern Med 1994;154:2417-22
69. Bhopal R. Source of infection for sporadic Legionnaires' disease. A review. J Infect 1995;30:9-12
70. Bhopal R, et al. Proximity of the home to a cooling tower and risk of non-outbreak Legionnaires' disease. BMJ 1991;302:378-82
71. Stout JE, Yu VL, Muraca P. et al. Potable water as a cause of sporadic cases of community-acquired Legionnaires' disease. N Engl J Med 1992;326:151-5
72. Yu VL. Kroboth FJ, Shonnard J, et al. Legionnaires' disease' new clinical perspective from a prospective pneumonia study. Am J Med 1982;73:357-61
73. Johnson JD, Roff M, Van Arsdall J. Neurologic manifestations of Legionnaires' disease. Medicine 1984;63:303-10
74. Kirby BD. Snyder K, Meyer R, et al. Legionnaires' disease. Report of 65 nosocomially acquired cases and a review of the literature. Medicine 1980;59:188-205
75. Ruf B, Shurmann D, Horbach I, et al. Frequency and diagnosis of Legonella pneumonia: a 3 year prospective study with emphasis on application of urinary antigen detection. J Infect Dis 1990;62:1341-7
76. Miller MF, Martin J, Johnson P, et al. Erythromycin uptake and accumulation by human polymorphonuclear leukocytes and efficacy of erythromycin in killing of ingested L pneumophila. J Infect Dis 1984;149:714-8
77. Vilde J, Dournon E, Rajagopalan P. Inhibition of L. pneumophila multiplication within human macrophages by antimicrobial agents. Antimicrob Agents Chemother 1986;30:743-8
78. Grayston JT, Wang SP, Kuo CC, Campbell LA. Current knowledge on Chlamydia pneumonia, strain TWAR, an important cause of pneumonia and other acute respiratory diseases. Eur J Clin Microbiol Infect Dis 1989;8: 191-202
79. Marrie TJ, Grayston JT, Wang SP. Kuo CC. Pneumonia associated with the TWAR strain of Chlamydia. Ann Intern Med 1987;106:507-11
80. Thom DH, Grayston JT, Wang S-P, et al. Chlamydia pneumoniae strain TWAR, Mycoplasma pneumoniae and viral infections in acute respiratory disease in a university health clinic. Am J Epidemiol 1990;132:248-56
81. Hashiguchi K, Ogawa H, Kazuyama Y Seroprevalence of Chlamydia pneunomiae infections in otolaryngeal diseases. J Laryngol Otol 1992;106:208-10
82. Huovinen P, Lahtoner R, Ziegler T, et al. Pharyngitis in adults: the presence and coexistence of viruses and bacterial organisms. Ann Intern Med 1989;110:612-6
83. Ogawa H, Fujisawa T, Kazuyama Y. Isolation of Chlamydia pneumamae from the middle ear aspirates of otitis media with effusion. Case report. J Infect Dis 1990;162:1000-1
84. Beaty CD. Grayston JT, Wang S-P, et al. Chlamydia pneumoniae strain TWAR in patients with chronic obstructive pulmonan disease. Am Rev Respir Dis 1991;144:1408-10
85. Augenbraun MH, Roblin PM, Mandel LJ, et al. Chlamydia pneumoniae pneumonia with pleural effusion: diagnosis by culture. Am J Med 1991;91:437-8
86. Augenbraun MH, Roblin PM, Chirgwin K, et al. Isolation of Chlamydia pneumoniae from the lungs of patients infected with the human immunodeficiency virus. J Clin Microbiol 1991;29:401-2
87. Clark R, Mashatt D, Fazal B. Case report. Chlamydia pneu-moniae pneumonia in an HIV-infected man. Am J Med Sci 1991;302:155-6
88. Miller ST, Hammerschlag MR, Chirgwin K, et al. Role of Chlamydia pneumoniae in acute chest syndrome in sickle cell disease. J Pediatr 1991;118:30-3
89. Marrie TJ, Harczy M, Mann OE, et al. Culture negative endocarditis probably due to Chlamydia pneumoniae. J Infect Dis 1990;161:127-9
90. Frydén A, Kihlström E, Maller R, Persson K, Romanus V, Ǎnséhn S. A clinical and Chlamydia pneumoniae (strain TWAR). Scand J Infect Dis 1980;21:681-91
91. Haidl S, Ivarsson S, Bjerre I, Persson K. Guillain Barre syndrome after Chlamydia pneumoniae infection. N Engl J Med 1992;326:576-7
92. Braun J, Laitko S, Treharne J, et al. Chlamydia pneumoniaea new causative agent of reactive arthritis and undifferentiated oligoarthritis. Ann Rheum Dis 1994;53:100-5
93. Hahn DL, Dodge RW, Golubjatnikov R. Association of Chlamydia pneumoniae (strain TWAR) infecton with wheezing, asthmatic bronchitis, and adult-onset asthma. JAMA 1991;266:225-30
94. Saikku P, Leinonen M, Mattila K, et al. Serological evidence of an association of a novel Chlamydia TWAR, with chronic coronary artery disease and acute myocardial infarction. Lancet 1988;2:983-6
95. Saikku P, Leinonen M, Tenkanen L, et al. Chronic Chlamydia pneummiae infection as a risk factor for coronary heart disease in the Helsinki Heart Study. Ann Intern Med 1992:116:273-8
96. Thorn DH, Grayston JT, Siscovick DS, et al. Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease. JAMA 1992:268:68-72
97. Chirigwin K, Roblin PM, Hammerschlag MR. In vitro susceptibilities of Chlamfdia pneumomae ( Chlamydia sp strain TWAR). Antimicrob Agents Chemother 1989;33:1634-5
98. Grayston JT. Chlamydia pneumoniae strain TWAR. Chest 1989:95:664-9
99. Lipsky BA, Tack KJ, Kuo C-C, et al. Ofloxacin treatment of Cklamydia pneumonia? (strain TWAR) lower respiratory tract infections. Am J Med 1990;89:722-4
100. Msc Farlane JT, Macrae AD. Psittacosis. Br Med Bull 1983:39:163-7
101. Buttery RB, Wreighitt TG. Outbreak of psittacosis associated with a cockatiel. Lancet 1987;ii:742-3
102. Nagington J. Psittacosis/ornithosis in Cambridgeshire 1975-1983. J Hyg, Camb. 1984:92:9-19
103. Anonymous. Psittacosis of non-avian origin. Lancet 1984;ii: 442-3
104. Maffei C, Ditanislao F, Pausi P, dementi M. Psittacosis of non-avian origin. Lancet 1984;ii:806
105. Beer RJS, Bradford WP, Hart RJC. Pregnancy complicated by psittacosis acquired from sheep. Br Med J 1982;284: 1156-7
106. Regan RJ, Datnan JRE, Treharne JD. Infective endocarditis with glomerulonephritis associated with cat chlamydia (C. psitticf) infection. Br Heart J 1979;42:349-52
107. Grayston JT, Kuo C-C, Wang S-P, Altman J. A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections. N Engl J Med 1986;315:161-8
108. Pether J VS, Wang S-P, Grayston Jr. Chlamydia pneumoniae, strain TWAR, as the cause of an outbreak in a boy's school previously called psittacosis. Epidemiol Inf 1989; 103:395-400
109. Wong KH, Skelton SK, Daugharty H. utility of compiement fixation and microimrnunofluorescence assays for detecting serologie responses in patients with clinically diagnosed psittacosis. J Clin Microbiol 1994;32:2417-21
110. Yung AP, Grayson ML. Psittacosis: a review of 135 cases. Med J Aust 1988;148:228-33
111. Semel JD. Cutaneous findings in a case of psittacosis. Arch Dermatol 1984;120:1227-9
112. Macheta MP, Ackrill P, August PJ. Psittacosis, panniculitis and clofazamine.J Infect 1994;28:69-71
113. Anonymous. More psittacosis. Br. Med J 1973;3:704
114. Shee CD. Cerebellar disturbance in psittacosis. Postgrad Med J 1988;64:382-3
115. Zumla A, Lipscomb G, Lewis D. Sixth nerve palsy complicating psittacosis. J Neurol Neurosurg Psych 1989;51: 1462
116. Prevett M, Harding AE. Intracranial hypertension following psittacosis. J Neurol Neurosurg Psychiatry 1993;56:425-6
117. Williams W, Sunderland R. As sick as a pigeon-psittacosis mvelitis. Arch Dis Child 1989:64:1626-8
118. Mason AB. Jenkins P. Acute renal failure in fulminant psittacosis. Respir Med 1994;88:239-40
119. Page SR, Stewart JT. Bernstein JJ. A progressive pericardial infusion caused by psittacosis. Br Heart J 1988;60:87-9
120. Day CJE, Fawcett IW. Psittacosis and acute thrombocytopenic purpura. J Roy Soc Med 1992;85:360-1
121. MacFarlaneJT, Miller AC, Smith WHR, et al. Comparative radiographic features of community-acquired Legionnaires' disease, pneumococcal pneumonia, mycoplasma pneumonia and psittacosis. Thorax 1984;39:28-33
122. Beebe JL. Emerging infections: hantavirus disease outbreak. Clin Microbiol Newsletter 1994;16:73-6
123. Nichol ST. Spiropoulou CF, Morzunov S, et al. Genetic identification of a Hantavirus associated with an outbreak of acute respiratory illness. Science 1993;262:914-7
124. Hughes JM, Peters CJ, Cohen ML, Mahy BVJ. Hantavirus pulmonary syndrome. An emerging infectious disease. Science 1993;262:850-1
125. Sands L. Rutherford GW, Hoffinan RE. Hantavirus pulmonary syndrome-United States. MMWR 1994;43:45-7
126. Anapol H, Greenrnan R, Kolber M, et al. Newly identified Hantavirus-Florida. MMWR 1994;43:99
127. Khan AS, Ksiazek TG, Zaki SR, et al. Fatal hantavirus pulmonary syndrome in an adolescent. Paediatrics 1995;95: 276-80
128. Buder JC, Peters CJ. Hantaviruses and hantavirus pulmonarv svndrome. Clin Infect Dis 1994;19:387-95